Observational studyThe Journal of clinical investigation2023

Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments.

Akshita Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.